News About: Pharm. Industry


Joy and sorrow feeling mixed in revised Fair Trade Act.

The Fair Trade Commission finally approved the revised fair trade provision raised by the KPMA, for which domestic and foreign drug companies took different feelings one another. The domestic companies favored the new...

Sports leisure facilities such as Ski resort can sell general medicines.

Sports leisure facilities such as condominium ski resorts and golf clubs can sell general medicines like painkillers without pharmacist from January, next year. Ministry of Health and Welfare stated on 21st that they...

Sang A on harsh backlash against KDB over M&A issue.

Sang A pharmaceutical company strongly wished to make the M&A process in an open public bidding, but they denounced the Korea Development Bank (KDB) because the KDB only attempted to decline it just for the sake of th...

KOSDAQ registration of Bio enterprises will grow 37% in next year.

Bio-industry is expected to record around 40% growth next year, as government increases investment in Bioengineering technology (BT). Kim Chi-hun, bio-industry analyst in Dongyang stock company stated in recent repor...

Medicine for Kids and Aged is necessary for occupying China's Market.

"Target Kids and Old Generation" Medicines for kids and old generation such as tonic for kids and medicine for circulation of blood is rising as main export commodity in occupying China's market which is going to o...

Novartis expresses will for price adherence of Glibeg

Korea Novartis showed that they couldn't accept the price 17,862won per capsule, which the ministry of welfare notified regarding Glibeg. Frank Bobe, President of Korea Novartis said, "the price (25,005won) which No...

KPMA starts full-scale operation of MR education system

Korean Pharmaceutical Manufactures Association held, ' explanation of MR education system' and started in full-scale preparation for processing MR system in association hall on 12th. Sin Suk-woo, Managing director of...

M&A and consolidation on rising trend in bio industry.

Recently the company organization enlargement and the company consolidation among the same business entities showed an ongoing stance in the world bio-engineering industry led by the United States while the number and...

Choongwae's Curoxin, new quinolone anti-bacterial drug, to launch soon.

Choongwe (President: Lee Kyung-ha) announced on Dec. 13 that they may get the health registration approval for Curoxin (Balofloxacin), a new quinolone antibacterial agent from the KFDA on Dec. 17 through the Central P...

Tendency of No-Loan Management in Medical Manufacturing Companies.

No-Loan management which medical manufacturers adopt for decreasing financial risk is increasing this year. Il-Sung sin yak, for the first time among medical manufacturing companies, in 1999,executed no-loan manageme...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.